GL1X · GenesisL1 explorer

Research workbench

Influenza neuraminidase in complex with antiviral compound (3S,4R,5R)- 4-(acetylamino)-3-amino-5-(pentan-3-YLOXY)CYCLOHEX-1-ene-1-carboxylic acid

Analyse Influenza neuraminidase in complex with antiviral compound (3S,4R,5R)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4KS1
Type
protein
Length
389 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Neuraminidase
UniProt
Q0A480
Ligands
2H8, NAG, CA
Pockets
2 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 47% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANeuraminidaseprotein3894% helix, 47% strandQ0A480

Ligands and binding sites

  • 2H8 · (3S,4R,5R)-4-(acetylamino)-3-amino-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A
  • CA · Calcium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12550.640.82392H8
2710.300.7418empty

Modifications

Observed in the structure: 8 disulfide, 1 glycan (disulfide, N-glycosylation).

Compared structures

  • 4KS1 · Influenza neuraminidase in complex with antiviral compound… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.